Autotransplantation of Purified CD34+cells for Critical Limb Ischemia Caused by Buerger Disease
Z. Dong,Y. Fang,T. Pan,H. Liu,Z. Wei,S. Gu,P. Liu,D. Guo,X. Xu,B. Chen,W. Fu
DOI: https://doi.org/10.1016/j.jcyt.2019.03.424
IF: 6.196
2019-01-01
Cytotherapy
Abstract:Background & Aim Buerger disease (BD) is associated with a substantial risk of amputation and loss of labor ability, and the conventional reconstruction seldom yields satisfactory mid-to-long-term results for it. The current study is to assess the efficacy of autotransplantation of purified CD34+cells (PCCs) for critical limb ischemia (CLI) in patients with BD. Methods, Results & Conclusion Methods From 2009 to 2017, 49 CLI patients with BD underwent autotransplantation of PCCs. Mean age was 41±13years (range 20-55), and all patients were not eligible for surgical or endovascular revascularization. G-CSF was subcutaneously injected for 5 days before apheresis. Then CliniMACS system was used to isolate the CD34+cells which were intramuscularly injected into the limbs. Patients were telephoned for inquiry about the rest pain every week during the first 3 weeks and followed-up at 1, 2, 3, 6, 9, 12 months and yearly thereafter. Results The mean number of transplanted cells (6.8±2.7) × 105/kg [(4.1 × 105-2 × 106)/kg]. The follow-up was accomplished in 47 cases, ranging from 12-103M (mean 55±25M), while two patients were missed. Wong-Baker FACES pain rating scale score significantly decreased from 9.0±2.0 (4-10) to 2.3±3.0(P<0.001) at 1 M. The Peak pain-free walking time was significantly improved from 3.9±2.0min to 15.5±5.8min (P<0.001) at 3M and 18.5±3.5min (P<0.001) at 6 M, respectively. The ankle-brachial index increased from 0.48±0.27 to 0.55±0.15 (P<0.05) at 3M and 0.58±0.14(P<0.05) at 6M, respectively. Transcutaneous partial oxygen pressure rose from 24±11mmHg to 49±11mmHg (P<0.001) at 3M and 59±10mmHg (P<0.001) at 6 M, respectively. Among 32 patients with ulcers, they were healed in 31 patients at 5±5 M (2-15M), while the ulcer was not healed in 1 patient who had above-knee amputation at 3M. Among the 10 patients with gangrene, the gangrened toe was spontaneously dropped off in 3 patients, while toe amputation was performed in 7 cases in whom the wound was healed in 6 patients and not healed in 1 patient who had the below-knee amputation at 1M. Additionally, CLI reoccurred in 1 patient at 31M and caused below-knee amputation. The overall major-amputation-free survival rate was 95.9% at 12M. Thirty-six patients (73.5%) got back to normal work at 12M. SF–36v2 scores were significantly improved at 12 months. Conclusions Autotransplantation of PCCs could achieve mid-to-long-term limb salvage, labor competence recovery and life quality improvement in patients with CLI caused by BD. Buerger disease (BD) is associated with a substantial risk of amputation and loss of labor ability, and the conventional reconstruction seldom yields satisfactory mid-to-long-term results for it. The current study is to assess the efficacy of autotransplantation of purified CD34+cells (PCCs) for critical limb ischemia (CLI) in patients with BD. From 2009 to 2017, 49 CLI patients with BD underwent autotransplantation of PCCs. Mean age was 41±13years (range 20-55), and all patients were not eligible for surgical or endovascular revascularization. G-CSF was subcutaneously injected for 5 days before apheresis. Then CliniMACS system was used to isolate the CD34+cells which were intramuscularly injected into the limbs. Patients were telephoned for inquiry about the rest pain every week during the first 3 weeks and followed-up at 1, 2, 3, 6, 9, 12 months and yearly thereafter.